Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 193-204 of 4,306
Device study icon
Not Yet RecruitingNCT07559084

Multi-target TMS for Schizophrenia Negative Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 16 Years to 45 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
Other study type icon
Not Yet RecruitingNCT06749041

Nor)Clozapine Kinetics and Side Effects in Therapy Resistant Schizophrenia and the Optimal Sampling Time for Therapeutic Drug Monitoring

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 70 Years
Countries
Sponsor
GGZ Noord-Holland-Noord
Condition
Schizophrenia
Drug study icon
Not Yet RecruitingNCT06474286

Prucalopride for Cognitive Functioning in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Mangalore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
India
Sponsor
University of Pittsburgh
Condition
Schizophrenia
Biological study icon
Not Yet RecruitingNCT07485751

Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms for schizophrenia

This study is not yet recruiting. It is testing Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBiologicalFrom 18 Years to 60 Years
Countries
Sponsor
Zigong Mental Health Center
Condition
Schizophrenia
Behavioral study icon
Not Yet RecruitingNCT05416658

Shared Decision Making for Antipsychotic Medications

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 30 Years
Countries
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
Not Yet RecruitingNCT06799559

QLM1016 for schizophrenia

This study is not yet recruiting. It is testing QLM1016 for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Sponsor
Qilu Pharmaceutical Co., Ltd.
Condition
Schizophrenia
Behavioral study icon
Not Yet RecruitingNCT07266376

Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS

This summary needs review. Please check the official study record and contact the research team for details.

In Les Abymes
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Condition
Schizophrenia
Other study type icon
Not Yet RecruitingNCT07108673

Value of Voxel-Based Morphometry in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 18 Years to 60 Years
Countries
Sponsor
Assiut University
Condition
Schizophrenia
Drug study icon
Enrolling By InvitationNCT07521683

NS-136 for schizophrenia

This study is enrolling by invitation in China. It is testing NS-136 for schizophrenia.

In Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
NeuShen Therapeutics
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.